Amici Clinical Research - Ownership and Business Overview

Life ScienceCompany

Amici Clinical Research Ownership

Who owns Amici Clinical Research?

Amici Clinical Research is owned by The IMA Group. It was acquired on March 2, 2022.

Amici Clinical Research Business Overview

Where is Amici Clinical Research headquartered?

Amici Clinical Research is headquartered in Raritan, New Jersey.

What sector is Amici Clinical Research in?

Amici Clinical Research is a life science company.

When was Amici Clinical Research founded?

Amici Clinical Research was founded in 2015.

Life Science M&A Summary in 2022

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.

Join Mergr to view all 293 acquisitions of life science companies in 2022, including 37 acquisitions by private equity firms, and 256 by strategics.

Amici Clinical Research

Amici Clinical Research

34 E Somerset St,
Raritan, New Jersey 08869
United States,
(732) 369-3480
www.amicicr.com

Amici Clinical Research is a clinical trials company with two New Jersey sites in Raritan and Hoboken. The company also has extensive experience conducting endocrinology, dermatology, and vaccine studies, among the fastest-growing categories of clinical research today. Amici Clinical Research was founded in 2015 and is based in Raritan, New Jersey.


 Subscribe to unlock this and 207,502
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.